Investors Sue BioAge Labs Over Securities Fraud Allegations
LOS ANGELES, Feb. 10, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, has announced the filing of a class action lawsuit against BioAge Labs, Inc. (“BioAge” or “the Company”) BIOA for allegedly violating federal securities laws.
Investors Encouraged to Take Action
Investors who bought the Company’s securities during its initial public offering (“IPO”) on September 26, 2024, are urged to contact the firm before March 10, 2025.
Contact Information for Potential Claimants
Shareholders who experienced losses can click here to participate in the lawsuit. For more information, contact Brian Schall at The Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, or call 310-301-3335. You can also visit the firm’s website at www.schallfirm.com, or email at bschall@schallfirm.com.
Details of the Allegations
The class action is currently not certified, meaning participants are not represented by an attorney until that certification occurs. Alternatively, investors can choose to remain absent from the class.
According to the Complaint, BioAge misled the market by making false statements. On December 6, 2024, the Company announced that it would halt its STRIDES Phase 2 trial of its main candidate, azelaprag, due to safety concerns. This action contradicted claims made at the IPO, where the Company stated that azelaprag had potential benefits for obesity therapy through incretin drugs. Consequently, the statements made by BioAge were found to be false and misleading, leading to significant financial consequences for investors once the truth emerged.
Join the Lawsuit to Seek Recovery
Investors are encouraged to join the case to seek recovery for their losses.
The Schall Law Firm is dedicated to representing investors worldwide and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under applicable law and rules of ethics.
CONTACT:
The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com
View original content to download multimedia: here
SOURCE The Schall Law Firm
Market News and Data brought to you by Benzinga APIs